Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_assertion type Assertion NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_head.
- NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_assertion description "[The development of parathyroid carcinoma has been associated with inactivating mutations of the Hyperparathyroidism type 2 (HRPT2) gene encoding parafibromin, a member of the human RNA Polymerase II-Associated Factor Complex (hPAF) and functionally linked to the Wingless type (Wnt) pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_provenance.
- NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_assertion evidence source_evidence_literature NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_provenance.
- NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_assertion SIO_000772 19148484 NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_provenance.
- NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_assertion wasDerivedFrom befree-2016 NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_provenance.
- NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_assertion wasGeneratedBy ECO_0000203 NP714793.RAf1TUVlsw4GxxEDUqSsdd_esQZK4gYv_DFKuDxSLp_DY130_provenance.